Benign Conditions

Articles

The primary outcome measure of the phase 3 ATHLETE study is the noninferiority of aquablation versus HoLEP in alleviating lower urinary tract symptoms related to benign prostatic obstruction.

Phase 3 study compares aquablation with HoLEP in patients with BPH

professor and vice chair of urology at Wake Forest University in Winston-Salem, North Carolina, is a co–editor in chief for 

In this interview, Alexis E. Te, MD, discusses the evolution of LUTS treatment, what primary care providers should include in their evaluation when seeing a patient with LUTS, and how he selects treatments for patients with BPH.

Expert pointers on BPH evaluation and treatment

"Retreatment is the new buzz word and is very controversial, as parameters keep changing," writes Gopal H. Badlani, MD.

Treating a man with benign prostatic disease requires complex decision-making

Tadfin is a once-daily capsule that combines 5 mg of tadalafil (Cialis) with 5 mg of finasteride (Proscar).

FDA accepts application for tadalafil/finasteride combo capsule for BPH

Benjamin P. Saylor is associate editor of Urology Times, an Advanstar Communications publication.

The test can help clinician determine whether a second procedure would be of benefit to a patient.

UroCuff makes it easier to assess bladder function in patients with BPH

Wayne Kuznar is a contributor to Urology Times.

There were also no reports of sexual dysfunction related to device or procedure and no reported cases of sustained de novo erectile dysfunction at 5 years.

Water vapor thermal therapy for BPH sustains efficacy at 5 years

The Optilume drug-coated balloon catheter system is used to treat patients with lower urinary tract symptoms related to benign prostatic hyperplasia.

Efficacy of drug-coated balloon catheter for BPH sustained at 1-year follow-up

Podcasts

The study encompassed the prostatic urethral lift (UroLift), water vapor thermal therapy (Rezum), and temporary implantable nitinol device (iTIND).

Study: New BPH treatments demonstrate efficacy

Videos

“The take-home message is that for the appropriate patient, each of [these] technologies works well,” says Richard K. Lee, MD, MBA.

Dr. Richard Lee on why it’s “a wonderful time” for BPH treatment

A procedural code is now available to hospitals in France enabling use of UroLift to treat men aged ≥50 years with symptoms of an enlarged prostate up to 100 cc.

Benign Prostatic Hyperplasia